During the past decade, RMH Regional Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "RMH Regional Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 18 trials, followed by "Agendia" with 1 trials sponsored, "Baim Institute for Clinical Research" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "RMH Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "RMH Regional Cancer Center" are "Head and Neck Cancer" (5 trials), "Prostate Cancer" (3 trials), "Brain and Central Nervous System Tumors" (2 trials), "Breast Cancer" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "RMH Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "RMH Regional Cancer Center" are "Drug" (17 trials), "Radiation" (17 trials), "Procedure" (10 trials), "Biological" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (18 trials), "conventional surgery" (8 trials), "cisplatin" (4 trials), "paclitaxel" (4 trials) and "filgrastim" (3 trials). Other intervention names were less common.

The vast majority of trials in "RMH Regional Cancer Center" are 21 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "RMH Regional Cancer Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in RMH Regional Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in RMH Regional Cancer Center, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

RMH Regional Cancer Center has several departments that took part in Clinical trials: "RMH Regional Canter Center" - 11 trials